Remifentanil prevents increases of blood glucose and lactate during cardiopulmonary bypass in pediatric cardiac surgery
Not Applicable
- Conditions
- Congenital heart disease
- Registration Number
- JPRN-UMIN000025139
- Lead Sponsor
- Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
children with glucose tolerance abnormality or hyperlactatemia
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose and lactate levels just before and after cardiopulmonary bypass
- Secondary Outcome Measures
Name Time Method